LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 26 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,083,464 | -24.3% | 2,353,141 | 0.0% | 0.76% | -21.2% |
| Q2 2023 | $17,272,055 | +182944.2% | 2,353,141 | 0.0% | 0.97% | +55.9% |
| Q1 2023 | $9,436 | +36.6% | 2,353,141 | +11.1% | 0.62% | +34.4% |
| Q4 2022 | $6,906 | -99.9% | 2,118,283 | 0.0% | 0.46% | -16.2% |
| Q3 2022 | $7,880,000 | +12.2% | 2,118,283 | -6.8% | 0.55% | +3.8% |
| Q2 2022 | $7,024,000 | -42.1% | 2,273,221 | 0.0% | 0.53% | -43.0% |
| Q1 2022 | $12,139,000 | +9.7% | 2,273,221 | 0.0% | 0.93% | +41.6% |
| Q4 2021 | $11,069,000 | -45.1% | 2,273,221 | 0.0% | 0.66% | -19.7% |
| Q3 2021 | $20,155,000 | -3.4% | 2,273,221 | -2.1% | 0.82% | +15.5% |
| Q2 2021 | $20,869,000 | -43.9% | 2,321,403 | -1.5% | 0.71% | -14.5% |
| Q1 2021 | $37,193,000 | – | 2,356,000 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |